Andreas Halvorsen – TRVI history
- Issuer:
- TREVI THERAPEUTICS INC
- Quarters tracked:
- 18 (Q3 2022 → Q1 2026)
- Current shares:
- 3,198,644
- Current value:
- $38.16M
- Peak shares:
- 5,128,875 (Q3 2025)
- Overall change:
- -27%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 3,198,644 | $38.16M | $11.93 | 0 | 0% |
| Q4 2025 | 3,198,644 | $40.05M | $12.52 | -1,930,231 | -38% |
| Q3 2025 | 5,128,875 | $46.93M | $9.15 | +3,585,875 | +232% |
| Q2 2025 | 1,543,000 | $8.44B | $5470.00 | 0 | 0% |
| Q2 2025 | 1,543,000 | $8.44M | $5.47 | -1,684,792 | -52% |
| Q1 2025 | 3,227,792 | $20.30M | $6.29 | 0 | 0% |
| Q1 2025 | 3,227,792 | $20.30B | $6290.00 | -1,172,208 | -27% |
| Q4 2024 | 4,400,000 | $18.13M | $4.12 | 0 | 0% |
| Q4 2024 | 4,400,000 | $18.13B | $4120.00 | 0 | 0% |
| Q3 2024 | 4,400,000 | $14.70M | $3.34 | 0 | 0% |
| Q2 2024 | 4,400,000 | $13.11M | $2.98 | 0 | 0% |
| Q1 2024 | 4,400,000 | $15.18M | $3.45 | 0 | 0% |
| Q4 2023 | 4,400,000 | $5.90B | $1340.00 | 0 | 0% |
| Q3 2023 | 4,400,000 | $9.59B | $2180.00 | 0 | 0% |
| Q2 2023 | 4,400,000 | $10.52B | $2390.00 | 0 | 0% |
| Q1 2023 | 4,400,000 | $8.14B | $1850.00 | 0 | 0% |
| Q4 2022 | 4,400,000 | $8.49M | $1.93 | 0 | 0% |
| Q3 2022 | 4,400,000 | $6.78M | $1.54 | — | NEW |